missing translation for 'onlineSavingsMsg'
Learn More
Learn More
DiscoverX CAL-101 (Idelalisib, GS-1101)
Click to view available options
:
10 mg
Description
CAL-101 (Idelalisib, GS-1101, Zydelig) is a synthetic drug that potently inhibits the phosphoinositide 3-kinase P110Δ(PI3KΔ), with 40-300-fold selectivity over p110α, β, and γ. CAL-101 is FDA approved for treatment of chronic lymphocytic leukemia (CLL) in combination with rituximab. Provided as 10mg of dry powder.
Specifications
Specifications
| Quantity | 10 mg |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction